ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Cleveland BioLabs, Inc.
PR Newswire
NEW YORK, Oct. 21, 2020
NEW YORK
,
Oct. 21, 2020
/PRNewswire/ — Rowley Law PLLC is investigating potential securities law violations by Cleveland BioLabs, Inc. (NASDAQ: CBLI) and its board of directors concerning the proposed acquisition of the company by Cytocom, Inc. Cleveland BioLabs stockholders are expected to own 39% of the combined company. The Transaction is expected to close in the first quarter of 2021.
If you are a stockholder of Cleveland BioLabs, Inc. and are interested in obtaining additional information regarding this investigation, please visit us at:
/. You may also contact
Shane Rowley, Esq.
at Rowley Law PLLC, 50 Main Street Suite 1000,
White Plains, NY
10606, by email at
[email protected]
, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit
.
Attorney Advertising. Prior results do not guarantee a similar outcome.
View original content:
http://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-cleveland-biolabs-inc-301157196.html
SOURCE Rowley Law PLLC